Shares Magazine
888.00p+3.50 (+0.40%)02 May 2025, 19:14
Jump to:
Indivior PLC Fundamentals
| Company Name | Indivior PLC | Last Updated | 2025-05-02 |
|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
| Shares in Issue | 124.759 m | Market Cap | £1.11 bn |
| PE Ratio | 461.20 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | $0.02 | EPS Growth (%) | -0.25 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.2691 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | -4.8246 | Cash Equity Ratio | -1.3088 |
| Quick Ratio | 0.6129 | Current Ratio | 0.88 |
| Price To Book Value | 0 | ROCE | 0 |
Indivior PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Indivior PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | $139.00 m | $124.00 m | $85.00 m |
| Intangible Assets | $7.00 m | $13.00 m | $70.00 m |
| Investments | $27.00 m | $41.00 m | $98.00 m |
| Total Fixed Assets | $481.00 m | $494.00 m | $510.00 m |
| Stocks | $178.00 m | $135.00 m | $114.00 m |
| Debtors | $254.00 m | $254.00 m | $220.00 m |
| Cash & Equivalents | $320.00 m | $410.00 m | $893.00 m |
| Other Assets | $308.00 m | $316.00 m | $257.00 m |
| Total Assets | $1.32 bn | $1.76 bn | $1.77 bn |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | $939.00 m | $1.29 bn | $1.02 bn |
| Creditors after 1 year | $728.00 m | $662.00 m | $699.00 m |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $1.67 bn | $1.95 bn | $1.72 bn |
| Net assets | -$348.00 m | -$192.00 m | $51.00 m |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | $62.00 m | $68.00 m | $68.00 m |
| Share Premium | $90.00 m | $88.00 m | $14.00 m |
| Profit / Loss | $14.00 m | -$149.00 m | -$89.00 m |
| Other Equity | -$348.00 m | -$192.00 m | $51.00 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | -$348.00 m | -$191.00 m | $51.00 m |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | 0 | 0 | $0.84 |
| Debt-to-Equity | 0 | 0 | $5.22 |
| Assets / Equity | -4.8246 | -4.8246 | -4.8246 |
| Cash / Equity | -1.3088 | -1.3088 | -1.3088 |
| EPS | $1.19 | $1.60 | $1.36 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | $36.00 m | -$300.00 m | -$4.00 m |
| Cashflow before financing | -$66.00 m | -$364.00 m | -$105.00 m |
| Increase in Cash | $3.00 m | -$459.00 m | -$327.00 m |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | $1.19 bn | $1.09 bn | $901.00 m |
| Cost of sales | $231.00 m | $174.00 m | $151.00 m |
| Gross Profit | $957.00 m | $919.00 m | $750.00 m |
| Operating Profit | $32.00 m | -$156.00 m | -$81.00 m |
| Pre-Tax profit | $14.00 m | -$149.00 m | -$89.00 m |
Indivior PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world. |
| Latest Interim Date | 25 Jul 2024 |
| Latest Fiscal Year End Date | 20 Feb 2025 |
Indivior PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2018-03-22 | Mr. Cary J Claiborne | Executive Director,Chief Financial Officer |
| 2025-02-28 | Mr. Daniel A. Ninivaggi | Non-Executive Director |
| 2019-07-31 | Mr. Christian Stanton Schade | Non-Executive Director |
| 2019-08-29 | Ms. Lizabeth Herbst Zlatkus | Non-Executive Director |
| 2025-02-27 | Mr. Robert A. Schriesheim | Non-Executive Director |
| 2019-03-29 | Dr. Yvonne L Greenstreet, MB.Ch.B. | Non-Executive Director |
| 2020-09-04 | Mr. Howard Hao Pien | Non-Executive Director,Chairman |
| 2016-05-11 | Mr. Adrian Nevil Hennah | Non-Executive Director |
| 2024-12-31 | Mr. Graham Charles Hetherington | Non-Executive Director,Chairman |
| 2016-10-03 | Mr. Rupert Mark Boden Bondy | Non-Executive Director |
| 2020-07-31 | Ms. Tatjana Anni Hilde May | Non-Executive Director |
| 2022-12-28 | Mr. Daniel Joseph Phelan | Non-Executive Director,Senior Independent Director |
| 2025-03-20 | Mr. Mark Stejbach | Non-Executive Director |
| 2025-03-20 | Dr. Peter James Jonathan Bains | Non-Executive Director |
| 2024-12-31 | Mr. Jerome J. Lande | Non-Executive Director |
| 2023-09-29 | Ms. Lorna Mary Southcombe Parker | Non-Executive Director |
| 2021-01-11 | Mr. Daniel Tasse | Non-Executive Director,Senior Independent Director |
| 2020-06-29 | Mr. Shaun Thaxter | Executive Director,Chief Executive Officer |
| 2024-03-13 | Dr. Andrew Thomas McLellan | Non-Executive Director |
| 2025-03-20 | Ms. Juliet Thompson | Non-Executive Director,Senior Independent Director |
| 2025-03-17 | Mr. Mark Wesley Crossley | Executive Director,Chief Executive Officer |
| 2025-03-20 | Ms. Joanna Susan Le Couilliard | Non-Executive Director |
| 2025-03-20 | Dr. David E. Wheadon | Non-Executive Director,Chairman |
| 2025-03-20 | Mr. Ryan Preblick | Executive Director,Chief Financial Officer |
| 2025-03-11 | Mr. Keith Humphreys OBE | Non-Executive Director |
| 2025-03-20 | Mr. Joe Ciaffoni | Non-Executive Director |
Indivior PLC Contact Details
| Company Name | Indivior PLC |
|---|---|
| Address | 234 Bath Road, Slough, SL1 4EE |
| Telephone | +44 1753217800 |
| Website | https://www.indivior.com |
Indivior PLC Advisors
| Remuneration Consultant | Willis Towers Watson |
|---|---|
| Phone | +44 2071702000 |
| Fax | +44 2071702222 |
| Solicitor | Herbert Smith Freehills LLP |
|---|---|
| Phone | +44 2073748000 |
| Fax | +44 2073740888 |
| Financial PR Adviser | Tulchan Communications LLP |
|---|---|
| Phone | +44 2073534200 |
| Fax | +44 2073534201 |
| Remuneration Consultant | Deloitte LLP |
|---|---|
| Phone | +44 2079363000 |
| Fax | +44 2075831198 |
| Stockbroker | Morgan Stanley & Co International PLC |
|---|---|
| Phone | +44 2074258000 |
| Fax | +44 2074258990 |
| Stockbroker | Jefferies Hoare Govett |
|---|---|
| Phone | +44 2070298000 |
| Fax | +44 2070298010 |
| Financial Adviser | Jefferies Hoare Govett |
|---|---|
| Phone | +44 2070298000 |
| Fax | +44 2070298010 |
| Auditor | PricewaterhouseCoopers LLP |
|---|---|
| Phone | +44 2075835000 |
| Fax | +44 2078224652 |
| Solicitor | Slaughter and May |
|---|---|
| Phone | +44 2076001200 |
| Fax | +44 2070905000 |
| Registrar | Computershare Investor Services PLC |
|---|---|
| Phone | +44 3707020003 |
| Fax | +44 3707036101 |
| Solicitor | Covington & Burling LLP |
|---|---|
| Phone | +44 2070672000 |
| Fax | +44 2070672222 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Ferrexpo PLC | 77.70 | 7.92 |
| Clarkson PLC | 3,190.00 | 6.51 |
| Senior PLC | 146.20 | 6.25 |
| Alfa Financial Software Holdings PLC | 232.00 | 5.45 |
| Harbour Energy PLC | 160.90 | 5.23 |
| International Consolidated Airlines Group S.A. | 279.00 | 5.01 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Mobico Group PLC | 30.56 | -3.78 |
| Just Group PLC | 138.00 | -2.95 |
| Tbc Bank Group PLC | 4,700.00 | -2.89 |
| Sirius Real Estate LD | 93.10 | -2.82 |
| Ocado Group PLC | 274.20 | -2.80 |
| Watches Of Switzerland Group PLC | 349.40 | -2.62 |